TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– -68.2% +0.0% +2,019.8% -8.7% +94.9% -99.4% +7,332.8%
– – – – – – – -37.1%
– -68.2% +0.0% +2,019.8% -8.7% +94.9% -104.5% –
– +0.8% +0.0% +320.1% +19.4% -55.0% -21.4% -23.4%
– +24.3% +0.0% +320.0% -17.8% -27.0% -16.1% -2.7%
– +4.3% +0.0% +320.1% +12.9% -55.1% -13.8% -19.3%
– – – – – – – –
– +51.6% +46.4% +79.9% +90.6% +59.8% -23.1% -45.6%
– – – – – – – –
– – -99.6% +53,680.4% -73.0% +268.5% -101.0% –
– – – – – – – –
– – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?